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Ciguatoxins (CTX) are polyether neurotoxins that target
voltage-gated sodium channels and are responsible for ciguatera,
the most common fish-borne food poisoning in humans. This
study characterizes the global transcriptional response of mouse
liver to a symptomatic dose (0.26 ng/g) of the highly potent Pacific
ciguatoxin-1 (P-CTX-1). At 1 h post-exposure 2.4% of features on
a 44K whole genome array were differentially expressed (p £
0.0001), increasing to 5.2% at 4 h and decreasing to 1.4% by 24 h
post-CTX exposure. Data were filtered (|fold change| ‡ 1.5 and p £
0.0001 in at least one time point) and a trend set of 1550 genes
were used for further analysis. Early gene expression was likely
influenced prominently by an acute 4C decline in core body
temperature by 1 h, which resolved by 8 h following exposure. An
initial downregulation of 32 different solute carriers, many
involved in sodium transport, was observed. Differential gene
expression in pathways involving eicosanoid biosynthesis and
cholesterol homeostasis was also noted. Cytochrome P450s (Cyps)
were of particular interest due to their role in xenobiotic
metabolism. Twenty-seven genes, mostly members of Cyp2 and
Cyp4 families, showed significant changes in expression. Many
Cyps underwent an initial downregulation at 1 h but were quickly
and strongly upregulated at 4 and 24 h post-exposure. In addition
to Cyps, increases in several glutathione S-transferases were
observed, an indication that both phase I and phase II metabolic
reactions are involved in the hepatic response to CTX in mice.
Key Words: cytochrome P450; ciguatoxin; biotoxin; microarray;
liver; gene expression; hypothermia.
Ciguatoxins (CTXs) are lipid soluble, heat stable cyclic
polyethers produced by benthic marine dinoflagellates of the
genus Gambierdiscus. These potent activators of voltage-gated
sodium channels are bioaccumulated through trophic transfer
in reef associated fish and are responsible for causing ciguatera
fish poisoning (CFP) in humans, affecting 50,000–100,000
people each year (Fleming et al., 2006). CFP is the most
common marine poisoning and causes acute gastrointestinal
and neurological symptoms, including vomiting, diarrhea,
abdominal pain, severe localized itching, tingling of extremities
and lips, and thermal dysthesia (Lewis, 2006). Symptoms of
CFP can last from several weeks to, in some cases, several
years. Chronic symptoms include fatigue, weakness, depres-
sion, hypersensitivity to repeated exposure, and recurrence of
symptoms may occur upon consumption of nontoxic fish or
alcohol (Glaziou and Martin, 1992; Lewis, 2001, 2006). Suites
of CTX congeners with varying backbone structures have been
found to differ regionally and result in CFP with somewhat
different symptoms. In the Pacific Ocean, neurological symp-
toms dominate. Indian Ocean CFP is similar to the Pacific with
the addition of hallucinogenic symptoms, whereas gastrointes-
tinal symptoms predominate in the Caribbean (Lewis, 2006).
Pacific ciguatoxin-1 (P-CTX-1) is the most potent known
CTX and is the major congener found in carnivorous fish of the
region and, consequently, the predominant source of CFP in
the Pacific (Lewis, 2006). It is believed to be a fish metabolite
derived from oxidation of the parent CTX4A and CTX4B
(formerly called gambiertoxin) produced by Gambierdiscus
spp. from the Pacific region (Yasumoto and Murata, 1993).
This conversion results in 10 times more toxic potency to
mammals than the parent compounds, with 0.1 ng CTX/g fish
flesh eliciting symptoms in humans (Lehane and Lewis, 2000).
The 24 h LD50 of P-CTX-1 by ip injection in mice is 0.33 ng/g
(Dechraoui et al., 1999).
The metabolism of CTX in mammals has received almost no
investigation, primarily because of the lack of purified toxin
available to carry out such studies. The persistent and recurrent
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nature of ciguatera symptoms raises the possibility that CTX
and/or its metabolites may be stored and later mobilized.
Therefore, insight into the genomic response to CTX is
important to understanding both acute and chronic phases of
ciguatera poisoning. In a companion paper (Ryan et al., 2007),
we characterized the mouse immune response to CTX over an
acute time course and identified a predominantly Th2 immune
response, indicating an anti-inflammatory environment over the
first 24 h following CTX exposure. In a Th2 response, helper T
cells direct an immune environment that is thought to be
neuroprotective and may be advantageous to preventing neu-
ronal damage during exposure to CTX. In the current study, we
use oligonucleotide microarrays and real-time PCR to in-
vestigate the pathways in mouse liver responsive to P-CTX-1
over the same time course and, where relevant, relate the
concurrent responses observed in liver to the global immune
environment.
A key function of the liver is to metabolize xenobiotics. This
generally includes the biotransformation of lipophilic sub-
stances into more water-soluble metabolites prior to excretion.
The reactions to accomplish this are categorized into three
phases, hydroxylation (phase I), conjugation (phase II), and
transport (phase III). The cytochrome P450s (Cyps) are
a superfamily of heme proteins that are the main enzymatic
system for the metabolism of lipophilic substrates of varied
structures (Nebert and Russell, 2002; Nelson et al., 1996).
Together with other oxidases, reductases, and dehydrogenases,
Cyps are the primary enzyme system responsible for phase I
reactions in the hepatic system (Ziegler, 1994). Cyps catalyze
the attachment of a hydroxyl group to xenobiotics which
can then be used to facilitate phase II reactions, including
glucuronidation, sulfation, methylation, attachment of gluta-
thione, N-acetylation, or conjugation with amino acids
(Handschin and Meyer, 2003). Finally, in phase III reactions,
transporter proteins aid in the excretion of the metabolized
xenobiotic.
Although the role of Cyps and other drug-metabolizing
enzyme systems in the mammalian response to CTX have not
been investigated, studies have been carried out on a structur-
ally related cyclic polyether toxin, brevetoxin, which acts on
the same site on voltage-gated sodium channels. Exposure of
striped bass to brevetoxin congener PbTx-2 has been shown to
increase the activity of CYP1a, a phase I enzyme, and
glutathione S-transferase (GST), a phase II enzyme (Washburn
et al., 1996). In vitro studies demonstrate that CYP1a2,
CYP2a2, CYP2c11, CYP2d1, and CYP3a1 are all able to
catalyze the metabolism of PbTx-2 in rat hepatocytes (Radwan
and Ramsdell, 2006). In the only study of transcriptional
profiling in mouse liver following PbTx exposure, Walsh et al.
(2003) found few changes in expression, however a Cyp4a14
was induced. Thus, it has been shown that classical pathways
are involved in the metabolism of a ladder-like polyether toxin
similar to P-CTX-1. In this study the relative genomic
responses of liver to these marine toxins are further evaluated.
MATERIALS AND METHODS
Exposure to P-CTX-1. All studies were conducted at Duke University in
accordance with institutional and NIH guidelines for the ethical care and use of
laboratory animals. Adult male C57/BL6 mice were maintained on a 12:12 h
light:dark cycle and were given food and water ad libitum. Radio frequency
transmitters were implanted in the mice to measure core temperature and motor
activity as previously published (Gordon et al., 2001). Briefly, mice were
anesthetized with ketamine HCl and a sedative analgesic, medetomidine HCl,
and the transmitter (TA10TA-F40; Data Science International Sciences,
St Paul, MN) was implanted in the abdominal cavity. Following surgery, mice
were administered atipamezol HCl ip to counteract the anesthetic effect of
ketamine. The mice were allowed at least 10 days of recovery before testing
while animal health was monitored.
On the day of exposure, mice were weighed and randomly assigned to
control or experimental groups. Three groups of control mice (n ¼ 3) were
injected ip with a single dose of physiological saline with 1% Tween 60
(vehicle). Three groups of experimental mice (n ¼ 3) were injected ip with
0.26 ng/g P-CTX-1 in vehicle. P-CTX-1, obtained from Dr. Richard Lewis
(University of Queensland, Australia), was purified from moray eel liver as
described in Lewis et al. (1991) with > 90% purity. Core temperature and
motor activity were collected into 5 min bins as previously published (Bottein
Dechraoui et al., 2008). At 1, 4, and 24 h post-injection, three experimental
mice and three time-matched controls were anesthetized with 50 mg/ml sodium
pentobarbital ip. Livers were immediately dissected, flash frozen in liquid
nitrogen, and stored at 80C until RNA processing. Whole blood samples
were collected from the orbital sinus at 30 min and by heart puncture at 1, 4,
and 24 h and stored in ethylenediaminetetraacetic acid at 4C until extraction.
Blood CTX concentrations. Extraction of CTX from blood was carried
out using the procedure of Bottein Dechraoui et al. (2007). Briefly, blood was
extracted with acetonitrile, samples were centrifuged and the supernatant
collected and evaporated to dryness. The residue was dissolved in methanol.
The concentration of CTX equivalents in blood extracts was determined using
the N2A cytotoxicity assay as described in detail by Bottein Dechraoui et al.
(2007).
RNA processing. The livers of the three control mice for each time point
were pooled prior to RNA extraction, whereas RNA was extracted from livers
of individual CTX-exposed mice. The livers were crushed using a BioPulverizer
(BioSpec Products, Inc., Bartlesville, OK) in liquid nitrogen. The crushed tissue
was immediately placed in cooled Tri-Reagent (Molecular Research Center,
Inc., Cincinnati, OH) and homogenized using a Tissue-Tearor (United Lab
Plastics, St Louis, MO) at 25,000 rpm for 1 min on ice. All homogenates were
processed according to the manufacturer’s protocol. RNA was resuspended in
nuclease-free water and cleaned using an RNeasy midi-column (Qiagen,
Valencia, CA) according to manufacturer’s protocol. RNA was then quantified
using a NanoDrop ND-1000 (Wilmington, DE) and qualified on an Agilent
2100 Bioanalyzer (Foster City, CA).
RNA labeling and array hybridization. Four hundred and fifty nanograms
of total RNA from control and experimental animals was separately amplified
and labeled with either Cy3- or Cy5-labeled CTP (Perkin Elmer, Waltham, MA)
using Agilent’s Low Input Linear Amplification kit according to manufacturer’s
protocol. Following labeling and clean up, amplified RNA and dye incorporation
were quantified using a NanoDrop ND-1000. One microgram each of Cy3- and
Cy5-labeled targets were combined and hybridized to an Agilent catalog 44K
whole genome mouse oligonucleotide array for 17 h at 60C. After hybridization,
arrays were washed consecutively in solutions of 63 saline-sodium phosphate-
EDTA buffer (SSPE) with 0.005% N-lauroylsarcosine and 0.063 SSPE with
0.005% N-lauroylsarcosine for 1 min each at room temperature. This was
followed by a final 30 s wash in Agilent Stabilization and Drying solution. Three
biological replicates, including a dye swap, were performed at each time point.
Microarray analysis. Microarrays were imaged on an Agilent microarray
scanner, extracted with Agilent Feature Extraction software version A8.5.1, and
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data analyzed with Rosetta Resolver 5.1 gene expression analysis system (Rosetta
Informatics, Seattle, WA) using Agilent Design File 012694_D_G2_20051010.
Features were subjected to a combination linear and LOWESS normalization
algorithm using a rank consistency filter. Resolver generated a weighted
average composite array from the replicates (n ¼ 3) for each time point based
on the error model for the Agilent platform (Weng et al., 2006). The composite
arrays were used for a trend analysis to determine the expression pattern of
genes throughout the time course. Only features with absolute differential
expression of 1.5 fold or greater and a composite p value  104 in at least one
time point were included in trend analyses. These data were then clustered
using a Euclidean metric by a K-means clustering algorithm. The trend set was
further analyzed using web tool DAVID (Database for Annotation, Visuali-
zation and Integrated Discovery) to identify biological themes in the data set
(Dennis et al., 2003). DAVID calculates a modified Fisher Exact p value to
demonstrate gene enrichment, where p values less than 0.05 are considered to
be strongly enriched in the annotation category. A sequence set of all array
features with DAVID IDs was used as the background for enrichment analyses.
Untrended data from the composite arrays was analyzed in GenMAPP (Gene
Map Annotator and Pathway Profiler, Dahlquist et al., 2002; Doniger et al.,
2003; Salomonis et al., 2007) to elucidate and visualize differentially expressed
pathways in the data set.
Quantitative real-time PCR. Differentially expressed genes of interest
were selected for validation of the microarray results by quantitative real-time
PCR (qPCR). Triplicate reverse transcription reactions were carried out using
500 ng total RNA with an oligo(dT) primer using Ambion’s RETROscript Kit
(Austin, TX). Gene specific primers (Supplementary Table 1) were used for
qPCR on an ABI 7500 using the ABI Power SYBR Green master mix (Applied
Biosystems, Foster City, CA). The optimal annealing temperature for each
primer set was determined prior to the analysis of experimental samples. The
specificity of each primer set and size of the amplicon were verified by analysis
with Agilent’s Bioanalyzer 2100 and further confirmed by melting curve
analysis. The efficiency of each primer set was determined using a serial
dilution series of complimentary DNA (cDNA) from mouse liver. Duplicate
25 ll qPCR reactions were run from each cDNA triplicate. A cycle threshold
(Ct) was assigned at the beginning of the logarithmic phase of PCR
amplification and the difference in the Ct values of the control and experimental
samples were used to determine the relative expression of the gene in each
sample. Transmembrane protein 59 was used for normalization as its
expression did not change significantly in microarray or qPCR experiments
(ANOVA, p > 0.05). As data were not normally distributed (Shapiro–Wilk W
test), correlation to the microarray data set was determined by Spearman’s rho
using JMP version 5.1.2 (SAS Institute, Cary, NC).
RESULTS
Mouse Symptomatic Responses
The ip P-CTX-1 dose used in this study is approximately
80% of the LD50 in mice. All CTX exposed mice showed
hallmark symptoms of CTX exposure that were absent from the
time-matched controls, however no mortality was observed.
Early responses included diarrhea, piloerection, lacrimation,
and hypoactivity. All treated mice showed a rapid depression in
core body temperature (Fig. 1), which reached a minimum of
33C at 1 h and slowly returned to basal temperature (37C) by
8 h. Blood concentrations of CTX decreased rapidly from
26 pg equiv./ml at 30 min to 7 pg equiv./ml at 4 h, but
remained detectable at 24 h at 3 pg equiv./ml (Fig. 2). Blood
concentrations in control mice were below the limit of
quantification of 0.04 pg equiv./ml (data not shown; Bottein
Dechraoui et al., 2007). As the N2A cytotoxicity assay
measures CTX activity rather than structure, we cannot
determine if the decrease observed in the blood is due to
clearance or metabolism to less potent forms, or both.
Microarray Analysis
This study was conducted in a two color format, in which
total liver RNA from three individual mice exposed to P-CTX-
1 was compared with pooled total liver RNA from time-
matched control mice (n ¼ 3). The use of a pooled control
sample reduces technical variability, but may conceal bi-
ological variability in controls and result in higher false
predictions for certain genes. The analysis of individual
experimental animals provides insight into the biological
FIG. 1. Core body temperature pre- and post-injection. The core body
temperature of all mice was collected in 5 min bins for 1 h pre-injection and
continued for 24 h post-injection. Mice were injected with 0.26 ng/g P-CTX-1
(exposed) or vehicle (control) at time 0, as indicated by the gray arrow. Three
control and three exposed animals were sacrificed at 1, 4, and 24 h post-
injection, as indicated by the black arrows. The dark phase of the 12 h:12 h
light:dark cycle is shaded. Values plotted are the mean ± SEM. 1 to 1 h, n ¼
9; 1–4 h, n ¼ 6; 4–24 h, n ¼ 3.
FIG. 2. P-CTX-1 concentration in blood. The P-CTX-1 equivalents in
mouse blood following exposure to 0.26 ng/g P-CTX-1 as measured by N2A
cytotoxicity assay. Values plotted are the mean ± SEM (n ¼ 3).
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variability of the response to exposure, which is reflected in the
p value calculated for a given feature. In addition, coefficient of
variation calculations were examined for genes of interest to
assess the biological variability. Triplicate arrays from each
time point (1, 4, and 24 h) included a dye swap and underwent
weighted averaging by Resolver to produce a single composite
array at each time point. Using the error model for Agilent
arrays, Resolver calculates a p value for each feature based on
feature intensity, fold change, feature quality and variability
between arrays (Weng et al., 2006). A gene was deemed
‘‘signature’’ if the calculated p value was 0.0001 or less. At 1 h
979 (2.37%) of genes were called signature, whereas 2152
(5.22%) and 550 (1.35%) were signature at 4 and 24 h,
respectively. The ratios of up-:downregulation also varied
slightly among time points, with 0.71 at 1 h, 1.11 at 4 h, and
1.04 at 24 h. All raw gene expression data have been deposited
in NCBI’s Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo/, GEO Series accession number
GSE10768).
Trend analysis. For further analysis of gene expression
throughout the time course, a high quality trend set was
compiled including only those features that exhibited at least
1.5 fold change and a p  0.0001 in at least one time point.
This filtering resulted in a trend set of 1550 array probes
representing 1366 unique genes (Fig. 3, Supplemental Table 2).
The majority of genes (930) qualified for the trend set solely at
the 4 h time point. Several genes qualified at two time points
(162). Six genes qualified at all three time points: calbindin 3
(s100g), metallothionein 1K, Cyp4a14, apolipoprotein A-IV,
farnesyl diphosphate synthetase, and preimplantation protein 4.
Because genes that operate within a pathway are often
coordinately regulated, the trend set was then clustered by
K-means using a Euclidean distance metric to discern
subsets of genes with similar expression patterns. Membership
in a cluster can provide insight into the activation of specific
pathways and cross-talk between pathways. In subsequent
analyses, the ontology classification of individual clusters
indicates several temporally distinct processes initiated in
response to CTX.
Cluster 1 contains 400 array probes representing 344 unique
genes that, overall, show little change at 1 h, upregulation at
4 h, and varied responses at 24 h (Fig. 3). Analysis with
DAVID found this cluster to be enriched with genes classified
as cellular physiological process (p ¼ 2.88E5, 58.88% of
genes) and monooxygenase activity (p ¼ 2.42E4, 2.90% of
genes) (Table 1). Twelve solute carriers are in this cluster,
exhibiting 1.5 to 5.5 fold upregulation at 4 h. Three defensin-
related cryptdins were the largest changers, exhibiting 4.1 to
6 fold upregulation by 24 h. Eight Cyps and a Cyp
oxidoreductase (Por) are found in cluster 1, with upregulation
of 1.6 to 6.5 fold at 4 h and up to 3.9 fold at 24 h. Eight myosin
genes present show little change at 1 h, mild upregulation at 4 h
(þ1.7 to þ2.8 fold), and up to 3 fold downregulation by 24 h.
Peroxisome proliferator–activated receptor alpha (PPARa) and
two PPARc cofactors are also found in this cluster and exhibit
1.7 to 2.1 fold upregulation at 4 h.
Cluster 2 contains 382 array probes representing 361 unique
genes that exhibit slight downregulation at 1 h, transitioning to
upregulation at 4 h, and returning to basal or decreased levels at
24 h (Fig. 3). Gene ontology analysis found that negative
regulation of cellular process was the primary biological
process (p ¼ 1.02E4, 8.12% of genes) and molecular
function was found to be enriched for glutathione transferase
activity (p ¼ 4.98E5, 1.68% of genes) (Table 1). Fifteen
solute carriers are present, whose expression profiles differ
from the solute carriers in cluster 1 primarily by degree of
change, with no to mild downregulation at 1 h (1.1 to 2.1
fold), transient shift to upregulation (þ1.3 to þ3.8 fold) at 4 h,
and varying patterns of change at 24 h (4.4 to þ1.3 fold).
Two Cyps are found in this cluster, with Cyp4b1 showing
3.5 fold downregulation at 1 h. Seven glutathione S-transferases
exhibit slight downregulation at 1 and 24 h with upregulation at
4 h. Three kallikreins exhibit 1.5 to 1.9 fold change at 1 h.
FIG. 3. Cluster analysis of genes used for trending. The 1550 genes
comprising the trend set (|fold change|  1.5 and p  0.0001 in at least one
time point) were clustered by K-means using a Euclidean metric.
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This cluster also includes two probes for a myosin heavy chain
exhibiting 5.1 and 6.5 fold downregulation at 24 h.
Cluster 3 is the largest cluster containing 496 probes to 448
unique genes, most showing little change at 1 and 24 h and
downregulation at 4 h (Fig. 3). Analysis with DAVID found
this cluster to be enriched with genes from the following
annotation categories: sterol metabolism (p ¼ 2.43E11,
3.31% of genes) and GTPase (guanosine triphosphatase)
activity (p ¼ m2.29E3, 2.21% of genes) (Table 1). Kallikrein
12 is the largest changer at 1 h (þ4.7 fold) and also displays
strong downregulation at 4 h (3.6 fold). Sterol-C4-methyl
oxidase-like is the largest downregulated gene at 4 h (9.5
fold). This cluster contains several chemokine (C-X-C motif)
ligands displaying 1.6 to 2.7 fold downregulation at 4 h.
Several alpha and beta tubulin isoforms present in cluster 3
show 1.6 to 2.7 fold downregulation at 4 h. Four Cyp genes
present are downregulated either at 4 or 24 h (1.2 to 
4.4 fold).
Cluster 4 contains 183 probes representing 171 genes whose
expression generally peaked at 1 h post-CTX exposure, re-
turning to baseline thereafter (Fig. 3). Analysis with DAVID
found this cluster to be enriched with genes involved in the
biological process of digestion (p ¼ 1.29E3, 2.37% of genes)
and the molecular function of purine-nucleoside phosphorylase
activity (p ¼ 1.71E2, 1.18% of genes) (Table 1). Acyl-CoA
thioesterase 6 is the largest upregulated gene at 1 h post-CTX
exposure (þ28.7 fold). The acute phase anti-inflammatory
pancreatitis-associated protein is the largest downregulated
gene at 4 h (5.6 fold) and the greatest upregulated gene
(þ9.4 fold) at 24 h. Seven solute carriers are upregulated 1.6
to 5.4 fold at 1 h in this cluster. Two probes for a single Cyp,
Cyp51, displayed mild upregulation at 1 h (þ1.5 to þ1.7 fold)
and 24 h (þ1.7 to þ2.3 fold). A third probe for Cyp51 fell into
cluster 3, but exhibited a similar expression profile.
Cluster 5 is the smallest cluster, containing 89 probes
representing 82 genes that generally exhibit strong down-
regulation at 1 h, strong upregulation at 4 h, and variable
change at 24 h (Fig. 3). DAVID found this cluster to be
enriched with genes involved in sodium ion transport (p ¼
5.63E5, 7.14% of genes) and symporter activity (p ¼ 5.56E
5, 7.14% of genes) (Table 1). Transmembrane protein 27 was
the largest changer at both the 1 and 4 h time points, exhibiting
74.8 and þ97.4 fold change, respectively. Defensin beta 1
was strongly downregulated 5.1 fold at 1 h, but strongly
upregulated by 11 fold at 4 h, before returning to control levels
at 24 h. The nine solute carriers in this cluster, five of which are
known to be involved in sodium ion transport, showed strong
downregulation at 1 h (2.3 to 15.5 fold) and strong
upregulation (þ2.5 to þ26.8 fold) by 4 h post-CTX exposure.
The expression profiles of solute carriers in cluster 5 differ
from those in preceding clusters primarily by their larger
degree of downregulation at 1 h and by upregulation at 4 h.
Four Cyps showed downregulation at 1 h (2.3 to 8.6 fold),
strong upregulation at 4 h (þ5.1 to þ15.1 fold) and, with
the exception of Cyp4a14 (þ7 fold), return to control levels at
24 h. Lipin 1 was the greatest upregulated gene at 1 h
(þ2.2 fold), increasing to 14.4 fold at 4 h, but returning to
baseline by 24 h.
TABLE 1
GO Annotations from DAVID Analysis of Trend Set
Biological process p Value % Molecular function p Value %
Cluster 1 Cellular physiological process 2.88E05 58.88 Monooxygenase activity 2.42E04 2.90
(345) Muscle contraction 3.52E04 2.32 Iron ion binding 3.30E04 4.35
Negative regulation of apoptosis 4.74E04 2.90 Inositol or phosphatidylinositol kinase
activity
1.48E03 1.45
Cluster 2 Negative regulation of cellular process 1.20E04 8.12 Glutathione transferase activity 4.98E05 1.68
(357) Negative regulation of cellular
physiological process
3.35E04 7.00 Tissue kallikrein activity 1.88E03 1.12
Negative regulation of biological process 4.92E04 8.12 Catalytic activity 2.50E03 31.93
Cluster 3 Sterol metabolism 2.43E11 3.31 GTPase activity 2.29E03 2.21
(453) Sterol biosynthesis 6.61E11 2.43 Catalytic activity 8.04E03 30.02
Steroid biosynthesis 8.19E11 3.31 Isomerase activity 1.29E02 1.99
Cluster 4 Digestion 1.29E03 2.37 Purine-nucleoside phosphorylase activity 1.71E02 1.18
(169) Response to other organism 1.77E03 6.51 Pancreatic elastase activity 1.71E02 1.18
Alcohol metabolism 3.10E03 4.73 Elastase activity 2.55E02 1.18
Cluster 5 Sodium ion transport 5.63E05 7.14 Symporter activity 5.56E05 7.14
(84) Metal ion transport 6.84E04 9.52 Porter activity 2.30E04 8.33
Monovalent inorganic cation transport 1.21E03 8.33 Electrochemical potential-driven
transporter activity
2.36E04 8.33
Note. The 22806 features with DAVID IDs from the 44K feature array were used as the background population for enrichment analyses. The number of DAVID
IDs in each cluster are indicated in parentheses. p values are from a Fisher’s Exact test performed in DAVID and indicate enrichment. A p < 0.05 is considered
strongly enriched. % is the percent of genes in the cluster with the given GO annotation
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Cytochrome P450s. In all, 117 features on the 44K feature
array correspond to Cyps, representing 73 different isoforms of
the protein belonging to 17 families and 36 subfamilies. The
trend set contained 27 features corresponding to Cyps,
representing 19 different isoforms belonging to 10 families
and 13 subfamilies (Table 2). Details of the responses of all
Cyps on the array are listed in Supplemental Table 3. Within
the trend set, the greatest changes were seen in Cyp2j11,
Cyp2j13, and Cyp24a1, which were strongly downregulated at
1 h (3.2 to 8.6 fold) and strongly upregulated at 4 h (þ7.3
to þ15 fold), returning to baseline at 24 h. However, the
reported magnitude of some of these changes was biased by
a single animal (fold change coefficient of variation (CV) >
0.5, Table 2). Cyp2b9, Cyp2b10, and Cyp2b13 were also
strongly upregulated at 4 h (þ2.6 to þ6.5 fold), returning to
baseline at 24 h. Cyp4 family members, Cyp4a10, Cyp4a14,
and Cyp4a31 were also strongly upregulated at 4 h but
remained elevated at 24 h. Cyp39a1 showed a similar pattern,
although more modest in response. Fewer Cyps showed
significant downregulation. Cyp26a1 was significantly down
at 4 h (4 fold). Three probes for Cyp51 show a tendency
toward upregulation at 1 h, down at 4 h, and increased
expression again at 24 h. Where discrepancies are apparent
between multiple probes for the same gene (Supplemental Fig.
3), it is likely due to probe position on the ORF. Limitations to
the transcription efficiency of RNA polymerase result in poorer
amplification and noisier signals for the 5# located probes (e.g.,
for Cyp2j3 the probes are separated by approximately 1300 bp,
Cyp7a1 and Cyp51 2200 bp). When PCR confirmation of these
genes was carried out using primers located intermediately on
the ORF, the PCR results agreed with the average of the two
probes on the array.
GenMAPP Pathway Analysis
Expression data from the composite arrays at each time point
were imported into GenMAPP version 2.1 and MAPPFinder
2.0 beta to elucidate pathways responsive to P-CTX-1. Most
notably, the cholesterol biosynthesis pathway was strongly
downregulated 4 h post-CTX exposure, whereas showing little
TABLE 2
Cyp Genes Included in the Trend Set
Sequence name Accession no. Fold change, 1 h p Value, 1 h Fold change, 4 h p Value, 4 h Fold change, 24 h p Value, 24 h
Cyp2b9 NM_010000 1.403 1.94E07 5.595 < 1.00E45 1.002 0.9816
Cyp2b9 NM_010000 1.037 0.87689 3.508 2.23E06 1.020 0.95021
Cyp2b9a NM_009998 1.093 0.26423 2.613 3.26E14 1.031 0.82869
Cyp2b10 NM_009999 1.302 0.00247 6.453 2.39E22 1.144 0.39673
Cyp2b13 NM_007813 1.202 0.03139 5.422 1.25E40 1.161 0.34223
Cyp2e1 NM_021282 1.028 0.60286 1.628 <1.00E45 1.314 3.01E08
Cyp2j9 NM_028979 1.057 0.77224 1.977 5.97E18 1.076 0.4035
Cyp2j11 XM_131521 3.191 0.00001 7.266 0.00154 1.100 0.79608
Cyp2j13 NM_145548 8.609 1.44E40 15.080 5.03E12 1.421 0.68313
Cyp24a1 NM_009996 6.674 0.00516 11.997 1.40E07 1.153 0.85439
Cyp26a1 NM_007811 1.251 0.19293 4.436 3.31E08 1.005 0.96764
Cyp27a1 NM_024264 1.099 0.5301 1.652 1.68E22 1.322 0.00015
Cyp3a44 NM_177380 1.563 0.00323 1.160 0.25658 1.521 3.57E06
Cyp39a1 NM_018887 1.319 0.09214 1.570 0.0008 1.546 0.00003
Cyp4a10 NM_010011 1.749 0.02489 3.742 < 1.00E45 2.872 2.57E12
Cyp4a10 NM_010011 1.316 0.04669 3.665 6.62E18 3.854 2.45E08
Cyp4a10 X71478 1.200 0.40813 2.701 < 1.00E45 2.689 7.46E07
Cyp4a12b NM_177406 1.038 0.81421 1.976 3.64E15 2.143 0.00001
Cyp4a14 NM_007822 2.319 2.14E11 5.128 1.67E21 6.957 2.40E09
Cyp4a31c NM_201640 2.175 0.09152 4.592 1.51E33 4.208 6.10E09
Cyp4a31c NM_201640 1.487 0.02651 2.884 4.25E42 3.012 2.35E14
Cyp4b1 NM_007823 3.500 1.53E09 1.198 0.16258 1.112 0.14607
Cyp51 NM_020010 1.700 9.45E06 1.280 0.11997 2.316 1.48E16
Cyp51 NM_020010 1.534 2.12E09 1.365 0.00108 1.659 0.02252
Cyp51 AK028815 1.366 0.11714 2.093 3.41E13 1.539 0.08491
Cyp7a1 NM_007824 1.360 0.00511 1.695 7.15E13 1.390 0.23002
Cyp8b1 NM_010012 1.313 0.01685 2.827 2.94E19 1.446 0.25788
Note. Shaded values indicate data that met the fold change ( |1.5|) and p-value ( 0.0001) criteria required for trending, in addition to meeting a fold change
coefficient of variation (< 0.5) criteria.
aAnnotated as Cyp2b10 in Agilent design file 012694_D_G2_20051010.
bAnnotated as Cyp4a10 in Agilent design file 012694_D_G2_20051010.
cAnnotated as Cyp4a1 in Agilent design file 012694_D_G2_20051010.
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change at 1 h or 24 h (Fig. 4). Nearly every gene in the
pathway was strongly and/or significantly downregulated,
including Cyp51 as noted above. Given this response, it is
not surprising that analysis of the quality filtered down-
regulated genes at the 4 h time point by the functional
annotation tool DAVID found enrichment of genes involved in
sterol metabolism and biosynthesis (p ¼ 6.83E10, 2.64% of
genes and p ¼ 7.76E10, 1.94% of genes). At 24 h GenMAPP
analysis did not indicate significant changes in cholesterol
biosynthesis; however, DAVID analysis of filtered upregulated
genes at 24 h was found to be significantly enriched for sterol
metabolism and biosynthesis (p ¼ 1.24E7, 2.00% of genes
and p ¼ 1.31E7, 1.43% of genes). Upregulation of several
myosin, myosin binding, troponin, and actin genes at 4 h
resulted in several significant hits in the striated muscle
contraction pathway (data not shown). This pathway transi-
tioned to show downregulation by 24 h post-CTX exposure.
Likewise, analysis with DAVID of downregulated genes at 24
h indicated that they were enriched for genes involved in
muscle contraction (p ¼ 1.37E3, 1.38% of genes), the actin
cytoskeleton (p ¼ 5.20E5, 2.76% of genes), myosin (p ¼
5.52E4, 1.24% of genes), the sarcomere (p ¼ 1.48E2,
0.97% of genes), and structural constituents of the cytoskeleton
(p ¼ 4.3E2, 1.10% of genes).
As the role Cyps play in the metabolism of CTX were of
specific interest, the nuclear receptors involved in lipid
metabolism and toxicity were interrogated using relaxed filters,
to elucidate the possible involvement of multiple Cyps and
their corresponding transcription factors (Fig. 5). Overall,
limited mild and/or nonsignificant downregulation was ob-
served at 1 h post-exposure. This transitioned to, generally,
stronger upregulation at 4 h followed by more modest and/or
nonsignificant upregulation by 24 h post-CTX exposure.
Nuclear receptors responsive to CTX exposure included
PPARa, Nr1i2 (PXR), NR1i3 (CAR), and VDR. VDR was
the most extreme in its response with a 4.3 fold decrease at 1 h,
then 9 fold increase at 4 h, and 2.8 fold increase at 24 h. Its
expression corresponded with the expression patterns of its
targets, Cyp24a1 and Cyp3a13. Strong upregulation was also
seen in PPARa, which although not included in the pathway
map in Figure 5, also regulates Cyps 4a1 and 4a10, two of the
most highly upregulated Cyps at 4 h.
qPCR Validation
Eighteen genes were selected for verification by real-time PCR,
including transmembrane protein 59, used for normalization (Fig.
6). Tmem59 exhibited minor changes (< 1.2 fold) and good
correlation between microarray and qPCR (q¼ 1.0, p< 0.0001).
Overall, the changes in gene expression observed by qPCR
strongly supported the microarray results, exhibiting a correlation
of 0.93 across the time series (p < 0.0001, n¼ 54). The direction
of change agreed by both methods for 46 of 54 samples. Where
the direction of change was not conserved the magnitude of
change was, with one exception (Hmgcs at 1 h), always less than
1.4 fold. Below this threshold of 1.4 fold, increasing disagree-
ment between array and qPCR results has been observed (Morey
et al., 2006). At the 1 h time point Cyp2j11 and Cyp24a1 showed
much stronger downregulation by qPCR than microarray. The
measurements obtained by qPCR were highly repeatable and this
discrepancy is likely due to error in the array measurements
caused by low spot intensities following strong downregulation
of these genes. Even with this disparity in measurements for
these 2 genes, the correlation observed between methods at the 1
h time point was 0.86 (p < 0.0001, n ¼ 18).
DISCUSSION
This study examines the genomic response in liver to
a sublethal dose of the highly potent marine neurotoxin,
FIG. 4. Changes in the cholesterol biosynthesis pathway in response to CTX. All data from the 44K feature array were input to GenMAPP and MAPPFinder
to elucidate any changes in biochemical pathways in response to P-CTX-1 exposure. Cholesterol biosynthesis was found to be strongly downregulated at 4 h
post-exposure. This downregulation may be in response to the repression of SREBPs observed at 4 h post-exposure.
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FIG. 5. Changes in Cyps and their associated nuclear receptors in response to CTX. In order to elucidate any changes that may be taking place in phase I
detoxification enzymes, a map of nuclear receptors in lipid metabolism and toxicity was generated using a broad filter in GenMAPP and MAPPFinder. Although
significant changes were observed in many Cyps, including several not detailed on these maps, only minor and/or nonsignificant changes were observed in the
associated nuclear receptors.
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P-CTX-1. The toxic action of CTX is attributed to its potent
activation of voltage dependent sodium channels in brain,
heart, and muscle, leading to gastrointestinal (vomiting,
diarrhea), cardiac, and neurological symptoms that include
paresthesia and temperature dysthesia. Although direct targets
of CTX are not expected in liver based on its known mode of
action, the liver is the major site for detection and de-
toxification of xenobiotics. In addition, the liver transcriptome
is highly responsive to changes in an organism’s metabolic
state to maintain energy homeostasis. Indeed, we have
identified a set of 1550 features from the 44K array that
significantly changed in liver over the time course following
exposure that are reflective of changing metabolic demands
following CTX exposure and activation of detoxification
pathways. A major driver of the observed changes in gene
expression associated with metabolic homeostasis at early time
points following CTX exposure may be an acute suppression in
core body temperature. However, no gene expression data is
available corresponding to this regulated hypothermic response
in mice in response to other intoxicants. Therefore, clarification
of which responses are due to hypothermia and which are
directly responsive to CTX must await additional studies on
genomic responses to other temperature-suppressing xenobiotics.
Core Body Temperature
CTX-treated mice displayed symptoms typical of CTX
exposure including diarrhea, piloerection, hypoactivity, and
a rapid 4C decrease in core body temperature, which reached
a minimum at 1 h and slowly returned to baseline by 8 h.
Structurally related marine polyether toxins, including maito-
toxin and brevetoxin, cause similar acute stage hypothermia in
mice (Gordon et al., 1998, 2001) as do a variety of other xeno-
biotics including heavy metals, ethanol and organophosphates
(Gordon, 1993). This regulated hypothermic response in
rodents appears to be a programmed protective mechanism
against toxic insult that likely involves CNS thermoregulatory
centers that may be direct targets of CTX (Gordon and
Ramsdell, 2005). Induced hypothermia has protective effects in
liver from ischemic injury by inhibiting the hepatic in-
flammatory response, through the inhibition of inflammatory
cytokines tumor necrosis factor alpha, interleukin 1b (IL1b),
and macrophage inflammatory protein 2 (Kato et al., 2002).
In the current study, IL1b is significantly downregulated (5.9
fold) in liver by 4 h and remains down at 24 h, whereas other
inflammatory cytokines remain unchanged. Similarly, analysis
of blood gene expression in the animals from this experiment
(Ryan et al., 2007) found a predominant Th2, or anti-
inflammatory, immune environment throughout this acute phase
of CTX exposure with IL 1b downregulated 2.9 fold at 4 h.
Early Responding Genes
The gene expression responses observed at 1 h most likely
reflect, in part, metabolic responses to the observed core
temperature decrease. A majority of genes responding at 1 h
post-exposure exhibited downregulation (up:down ratio 0.71).
Solute carriers were highly represented in the gene set respon-
sive at 1 h, with 32 different solute carriers downregulated in
response to CTX exposure. These included several organic
FIG. 6. Validation of microarray results by real-time PCR. Eighteen genes,
including one normalizer (not shown), were selected for verification by qPCR.
The average value of qPCR assays on triplicate RT reactions and the weighted
average from array analyses are plotted. Overall a correlation of 0.93 was
observed (Spearman’s rho, p < 0.0001, n ¼ 54). The correlations at the 1, 4, or
24 h time points were 0.86, 0.91, and 0.86, respectively (Spearman’s rho, p <
0.0001, n ¼ 18).
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anion transporters, cation amino acid transporters, neurotrans-
mitter transporters, and glucose transporters, as well as several
transporters, symporters, or cotransporters involved in the
movement of sodium. Strong downregulation was observed in
Slc34a1, Slc34a3, Slc5a8, and Slc6a18, all involved in the
transport of sodium, which transitioned to very strong
upregulation by 4 h post-CTX exposure. The organic anion
transporters (oatps) play a key role in facilitating hepatic uptake
of many chemicals prior to biotransformation in the liver.
Downregulation of these transporters may indicate an initial
protective response of the liver to prevent excessive damage to
the hepatocytes (Cheng et al., 2005).
Of note among early upregulated genes were lipin 1 and 2,
demonstrating 2 to 3 fold upregulation 1 h post-CTX exposure.
Both lipins remained elevated at 4 h, with lipin 1 being among
the highest expressors at that time point (þ5.3 to þ14.4 fold).
Lipin 2, by contrast, although remaining up at 4 h (þ1.5 to
þ3.8 fold), appeared to be returning toward baseline. Both
lipins were at or below control levels by 24 h. The function of
lipins in liver is not fully elucidated, but they are nuclear
proteins that play a role in adiposity, glucose homeostasis, and
insulin sensitivity (Phan and Reue, 2005). Increased expression
of lipins has been shown to be regulated by the PPARc (Yao-
Borengasser et al., 2006), which may also impact Cyp
expression, however no changes in PPARc were observed
over this time course in response to P-CTX-1. Further,
increases in lipin have been shown to activate pathways of
mitochondrial fatty acid oxidative metabolism by triggering an
induction of PPARa (Finck et al., 2006). PPARa was
significantly upregulated 1.7 fold 4 h post-CTX exposure,
when core temperature was increasing.
Analysis with GenMAPP and MAPPFinder indicated
a significant downregulation of cholesterol biosynthesis at
4 h post-CTX exposure. The low-density lipoprotein receptor,
not included on this pathway map, but involved in regulating
cholesterol levels in the blood, was also significantly down-
regulated (2 fold) at 4 h, whereas exhibiting no change at 1
and 24 h. This may be in response to the downregulation of
sterol regulatory element-binding proteins (SREBPs, 2.6 fold
at 4 h) that are responsible for activating cholesterol bio-
synthesis (Horton et al., 2002). The expression of both
SREBPs and most components of the cholesterol biosynthesis
pathway had returned to basal levels by 24 h.
Late Responding Genes
By 24 h post-CTX exposure, most genes in the liver had
returned to basal expression levels. Exceptions to this trend
were several myosin genes, both heavy and light chains,
demonstrating 2.2 to 6.5 fold change at 24 h. Likewise,
several tropomyosin, troponin, and actin genes were down-
regulated at 24 h. This is in contrast to the increase of troponin
observed in mouse liver 24 h post-brevetoxin exposure (Walsh
et al., 2003), however an increase in these genes was observed
4 h post-CTX exposure. Sauviat et al. (2006) found that
P-CTX-1 caused swelling of erythrocytes due to activation of
the nitric oxide pathway by inducible nitric oxide synthase.
This swelling disrupted the actin cytoskeleton due to elevated
intracellular Ca2þ and may be a possible cause of down-
regulation of myosin, tropomyosin, and troponin. In addition,
the nitric oxide pathway has been shown to be activated by
insulin binding triggered by increased Ca2þ levels (Kahn et al.,
2000). In the current study, the insulin signaling pathway
showed a slight induction at 4 h post-CTX exposure in the
liver. There are also other indications that oxidative stress may
be elevated at that time point including the upregulation of the
pro-oxidant Cyp2e1 and several GSTs at 4 h (Kashida et al.,
2006; Shertzer et al., 2004; Yang et al., 2002).
Cyp Expression
Cyp enzymes in the liver occupy key positions in the
biosynthesis and metabolism of lipids including cholesterol,
bile acids, fatty acids, steroids, vitamin D, and eicosanoids.
A subset of hepatic Cyps are also responsible for the metabolism
of xenobiotics. To date 102 putatively functional Cyp genes
have been identified in mouse (Seliskar and Rozman, 2007),
many of which have unknown functions. The liver expresses
both the greatest number and diversity of Cyps (Choudhary et
al., 2003). Among these, Cyp families 1–4 are mainly involved
in the catabolism of both endogenous lipids and exogenous
lipophilic substrates (Gotoh, 1992). The ability of Cyps to
metabolize CTX has not previously been investigated and little
is known about metabolites in mammals that might shed light
on detoxification pathways involved.
The majority (63%) of Cyps included in the current trend set
are members of the Cyp2 or Cyp4 families, and the most
dramatic changes in Cyp expression were also observed among
these families. The Cyp2 and Cyp4 families are known to be
highly inducible and differentially expressed following expo-
sure to xenobiotics (Goetz et al., 2006; Handschin and Meyer,
2003). However, they also have roles in lipid metabolism that
confounds the question of whether they are activated
specifically in response to the presence of CTX. In addition,
hypothermia is known to suppress the activity of many Cyps
(Tortorici et al., 2007), however whether the observed decrease
in expression (Cyps 2j11, 2j13, 4a1, 4a10, 4a14, and others) is
an effect of the acute hypothermic response or the exposure to
CTX cannot be determined from the current study. Several
members of the Cyp 2 and Cyp 4 families (Cyps 2e1, 2j9, 2j11,
2j13, 4a10, and 4a14) were generally downregulated at 1 h and
upregulated at 4 h. Members of the Cyp2 family returned to
basal levels by 24 h, whereas member of the Cyp4 family
remained upregulated. These genes are involved in the
biosynthesis of eicosanoids, and their expression patterns
may reflect changes in the metabolic environment concurrent
with the hypothermic conditions at 1 h, followed by changes
occurring during the return to basal temperature, rather than
a direct response to the presence of a xenobiotic substrate.
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Cholesterol pathways are commonly disrupted in response to
xenobiotic exposure (Handschin and Meyer, 2005). Three
Cyps involved in the synthesis of bile acids from cholesterol
were upregulated at 4 h or 24 h, Cyp 27a1, Cyp8b1, and
Cyp39a1. Conversely, the rate limiting enzyme of this
pathway, Cyp7a1, which is feedback regulated by bile acids,
was downregulated at 4 h, at the same time that Cyp51 and
other members of the cholesterol biosynthesis pathway also
were downregulated. Cross-talk between nuclear receptors
regulating these endogenous metabolic pathways and those
mediating xenobiotic metabolism is widely recognized and not
fully understood (Handschin et al., 2002; Pascussi et al., 2004).
The expression of Cyps is regulated by several ligand-
activated transcription factors (Abdel-Razzak et al., 1993;
Beigneux et al., 2002, and others). Of these, the aryl
hydrocarbon receptor, constitutively active receptor (CAR),
and pregnane X receptor (PXR) are common xenobiotic
receptors. The upregulation of Cyps known to be involved in
xenobiotic metabolism observed at 4 and 24 h post-exposure
may therefore be indicative of their role in phase I metabolism
of CTX, with Cyp2b (2b9, 2b10), Cyp2j (2j9, 2j11, 2j13), and
Cyp4a (Cyp4a1, Cyp4a10, and Cyp4a14) family members
being candidates. Xenobiotics are often classified as activators
of specific nuclear receptors, and xenobiotic structure is
somewhat predictive of which Cyps may be involved in their
metabolism (Morgan et al., 1994; Waxman, 1999; Ziegler,
1994). Many structurally diverse compounds activate CAR and
PXR and induce transcription of Cyps, most are small in size
and highly lipophilic (Handschin and Meyer, 2005). However,
in the absence of studies on the direct activation of these
nuclear receptors of Cyps by CTX or other polyethers, it is not
known if the observed changes are a direct or indirect response
to P-CTX-1.
Cyp2 family members are generally considered to be
regulated by constitutively expressed CAR and inducible
PXR, which form heterodimers. When the current data set
was interrogated, PXR (Nr1i3 in Fig. 5) was upregulated at 4 h,
whereas CAR (Nr1i2) was constitutively expressed as
expected, concurrent with the maximal expression of these
Cyp2 family members. Similarly, PPARa was upregulated at
4 h, concurrently with its Cyp4 targets. Several other nuclear
receptors demonstrated coordinate expression with their targets,
including retinoic acid receptor RARb, which was downregulated
coordinately with Cyp26a1. Strong changes were also observed in
the vitamin D receptor (VDR), which is very closely related to the
xenobiotic-activated nuclear receptors and can activate several
Cyp genes, including the Cyp2b family (Handschin and Meyer,
2005). VDR was downregulated 4.3 fold at 1 h and was strongly
upregulated later in the time course (9.1 fold at 4 h and 2.1 fold at
24 h), an expression pattern mirrored by Cyp2b9 and Cyp2b10, as
well as Cyp24a, a mitochondrial vitamin D hydroxylase, which
was highly upregulated at 4 h.
A compendium of hepatic gene expression in response to
a wide array of xenobiotic compounds provides further insight
into the complexity of cross-talk between these induction
pathways (Slatter et al., 2006). Unfortunately, most hepatic
gene expression data is carried out following repeat exposures
or chronic exposure over multiple days, with gene expression
interrogated at 8–24 h following the final dose, such that
correlative analysis of the current results is not straightforward.
To our knowledge this is the first study to interrogate hepatic
gene expression during an acute hypothermic response to
intoxication in mice. Comparative studies will be needed to
clarify if the upregulation of the candidate Cyps are specific
to CTX or if they are a regulated response to the recovery
phase of hypothermia.
Comparison with Other Polyether Phycotoxins
Brevetoxin is a polyether toxin of similar structure as CTX
and similarly activates voltage dependent sodium channels.
Studies in mice have shown that brevetoxin also causes
a hypothermic response very similar to that observed following
CTX exposure (Gordon and Ramsdell, 2005). In vitro studies
of rat hepatocytes showed that CYP1a2, CYP2a2, CYP2c11,
CYP2d1, and CYP3a1 can metabolize brevetoxin-2 (Radwan
and Ramsdell, 2006). However, these genes either showed no
change in expression or were not included on the array used in
the current study. The absence of change in these Cyps may be
attributed to differences in the toxins tested, species-specific
differences in Cyp function, or post-transcriptional regulation
of their activity. Walsh et al. (2003) investigated the effects of
brevetoxin congeners PbTx-2 and -6 on gene expression in
mouse liver, using similar sub-LD50 doses ip. Gene expression
was interrogated at 8, 24, and 72 h following exposure. Only
0.3% of features were found to exhibit differential expression
in their study. If we apply the higher 1.74 fold cut-off used in
Walsh’s study to our CTX data, CTX appears to illicit a much
stronger response than does brevetoxin, with 2.6% of features
found to be differentially expressed following exposure to
P-CTX-1. Interestingly, a 2.4 fold increase in Cyp4a14 was
observed following 24 h exposure to brevetoxin-6. Cyp4a14
was upregulated 5 and 7 fold at 4 and 24 h in the current study.
The differences between hepatic responsiveness to these toxins
may reflect the time points queried as previous studies have
shown that, in rats, PbTx-2 is mostly cleared to the urine within
24 h and greater than 80% of PbTx-2 is metabolized within 4 h
in rat hepatocytes (Radwan and Ramsdell, 2006; Radwan et al.,
2005). Preliminary studies from our lab indicate that PbTx-3
delivered ip at approximately 75% of the LD50 yields moderate
changes in liver gene expression 4 h post-exposure. However,
many interesting parallels are observed in response to the two
different toxins. Many of the strongest downregulated genes 4
h post-PbTx-3 exposure are solute carriers involved in the
transport of sodium, whereas lipin 1 and an oxidative stress
response gene are strongly upregulated (Morey et al., un-
published data). Although in response to PbTx-3 only 10 Cyps
meet the fold change and p value filters used in this study, the
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trends observed are similar to those seen following CTX
exposure. Cyp7a1 and Cyp51 are significantly downregulated
4 h post-exposure to either toxin. In contrast, Cyps 2j6, 4a1,
4a10, and 4a14 and Cyp oxidoreductase are all significantly
upregulated in response to both brevetoxin and CTX (Morey
et al., unpublished data). A number of genes involved with
cholesterol biosynthesis were downregulated 4 h post-CTX
exposure in this study. No changes in these genes were
observed 4 h post-brevetoxin exposure (Morey et al., un-
published data). It is interesting to note that azaspiracid,
a polyether marine phycotoxin, caused significant upregulation
of the cholesterol biosynthesis pathway in an in vitro study of
human lymphocytes (Twiner et al., 2008).
CONCLUSIONS
Despite the prevalence of CFP as a worldwide foodborne
illness, the toxicological responses to CTX have received little
attention due to the limited availability of purified toxin for
such studies. This study provides the first insight into liver
responses to the lipophilic polyether P-CTX-1 using a toxico-
genomic approach. Several solute carriers, many involved in
sodium transport, were downregulated 1 h post-exposure.
Throughout the time course, differential gene expression in
pathways involving eicosanoid biosynthesis and cholesterol
homeostasis was observed. Following initial downregulation
that corresponds with the acute hypothermic response in mice
to intoxication, the strong responses of several Cyps at 4 and
24 h identified candidates for a role in phase I detoxification.
Several phase II enzymes were also induced 4 h following
exposure. This study may provide the basis for a further
understanding of the detoxification of a potent marine toxin in
mammalian systems.
SUPPLEMENTARY DATA
Supplementary data are available online at http://toxsci.
oxfordjournals.org/.
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